Combined in vivo depletion of glycoprotein VI and C-type lectin-like receptor 2 severely compromises hemostasis and abrogates arterial thrombosis in mice

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 33, Issue 5, 2013, Pages 926-934

  Bender, Markus ^a   May, Frauke ^a   Lorenz, Viola ^a   Thielmann, Ina ^a   Hagedorn, Ina ^a   Finney, Brenda A ^b   Vögtle, Timo ^a   Remer, Katharina ^a   Braun, Attila ^a   Bösl, Michael ^a   Watson, Steve P ^b   Nieswandt, Bernhard ^a  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

CLEC 2; GPVI; hemostasis; platelets; thrombosis

Indexed keywords

GLYCOPROTEIN VI; GLYCOPROTEIN VI ANTIBODY; LECTIN RECEPTOR; LECTIN RECEPTOR CLEC2; LECTIN RECEPTOR CLEC2 ANTIBODY; PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY THROMBOSIS; ARTICLE; BLEEDING TIME; BLOOD CLOTTING; CONTROLLED STUDY; DOWN REGULATION; HEMOSTASIS; IMMUNORECEPTOR TYROSINE BASED ACTIVATION MOTIF; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOCYTE;

ANIMALS; HEMOSTASIS; LECTINS, C-TYPE; MALE; MICE; MICE, INBRED C57BL; PLATELET MEMBRANE GLYCOPROTEINS; THROMBOSIS;

EID: 84876289215     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.112.300672     Document Type: Article

References (33)

1. Michelson AD. Antiplatelet therapies for the treatment of cardiovascular disease. Nat Rev Drug Discov. 2010;9:154-169.
2. Jackson S P. Arterial thrombosis-insidious, unpredictable and deadly. Nat Med. 2011;17:1423-1436.
3. Nieswandt B, Pleines I, Bender M. Platelet adhesion and activation mechanisms in arterial thrombosis and ischaemic stroke. J Thromb Haemost. 2011;9 suppl 1:92-104.
4. Arthur JF, Dunkley S, Andrews RK. Platelet glycoprotein VI-related clinical defects. Br J Haematol. 2007;139:363-372.
5. Kato K, Kanaji T, Russell S, Kunicki TJ, Furihata K, Kanaji S, Marchese P, Reininger A, Ruggeri ZM, Ware J. The contribution of glycoprotein VI to stable platelet adhesion and thrombus formation illustrated by targeted gene deletion. Blood. 2003;102:1701-1707.
6. Lockyer S, Okuyama K, Begum S, Le S, Sun B, Watanabe T, Matsumoto Y, Yoshitake M, Kambayashi J, Tandon NN. GPVI-defcient mice lack collagen responses and are protected against experimentally induced pulmonary thromboembolism. Thromb Res. 2006;118:371-380.
7. Bender M, Hagedorn I, Nieswandt B. Genetic and antibody-induced glycoprotein VI defciency equally protects mice from mechanically and FeCl(3)-induced thrombosis. J Thromb Haemost. 2011;9:1423-1426.
8. Nieswandt B, Bergmeier W, Schulte V, Rackebrandt K, Gessner JE, Zirngibl H. Expression and function of the mouse collagen receptor gly-coprotein VI is strictly dependent on its association with the FcRgamma chain. J Biol Chem. 2000;275:23998-24002.
9. Dütting S, Bender M, Nieswandt B. Platelet GPVI: a target for antithrom-botic therapy?! Trends Pharmacol Sci. 2012;33:583-590.
10. Nieswandt B, Schulte V, Bergmeier W, Mokhtari-Nejad R, Rackebrandt K, Cazenave JP, Ohlmann P, Gachet C, Zirngibl H. Long-term antithrombotic protection by in vivo depletion of platelet glycoprotein VI in mice. J Exp Med. 2001;193:459-469.
11. Bender M, Hofmann S, Stegner D, Chalaris A, Bösl M, Braun A, Scheller J, Rose-John S, Nieswandt B. Differentially regulated GPVI ectodomain shedding by multiple platelet-expressed proteinases. Blood. 2010;116:3347-3355.
12. Boylan B, Berndt MC, Kahn ML, Newman PJ. Activation-independent, antibody-mediated removal of GPVI from circulating human platelets: development of a novel NOD/SCID mouse model to evaluate the in vivo effectiveness of anti-human platelet agents. Blood. 2006;108:908-914.
13. Suzuki-Inoue K, Fuller GL, García A, et al. A novel Syk-dependent mechanism of platelet activation by the C-type lectin receptor CLEC-2. Blood. 2006;107:542-549.
14. Fuller GL, Williams JA, Tomlinson MG, Eble JA, Hanna SL, Pöhlmann S, Suzuki-Inoue K, Ozaki Y, Watson SP, Pearce AC. The C-type lectin receptors CLEC-2 and Dectin-1, but not DC-SIGN, signal via a novel YXXL-dependent signaling cascade. J Biol Chem. 2007;282:12397-12409.
15. Séverin S, Pollitt AY, Navarro-Nuñez L, Nash CA, Mourão-Sá D, Eble JA, Senis YA, Watson SP. Syk-dependent phosphorylation of CLEC-2: a novel mechanism of hem-immunoreceptor tyrosine-based activation motif signaling. J Biol Chem. 2011;286:4107-4116.
16. Bertozzi CC, Schmaier AA, Mericko P, et al. Platelets regulate lymphatic vascular development through CLEC-2-SLP-76 signaling. Blood. 2010;116:661-670.
17. Suzuki-Inoue K, Inoue O, Ding G, Nishimura S, Hokamura K, Eto K, Kashiwagi H, Tomiyama Y, Yatomi Y, Umemura K, Shin Y, Hirashima M, Ozaki Y. Essential in vivo roles of the C-type lectin receptor CLEC-2: embryonic/neonatal lethality of CLEC-2-defcient mice by blood/lymphatic misconnections and impaired thrombus formation of CLEC-2-defcient platelets. J Biol Chem. 2010;285:24494-24507.
18. Finney BA, Schweighoffer E, Navarro-Núñez L, et al. CLEC-2 and Syk in the megakaryocytic/platelet lineage are essential for development. Blood. 2012;119:1747-1756.
19. Bertozzi CC, Hess PR, Kahn ML. Platelets: covert regulators of lymphatic development. Arterioscler Thromb Vasc Biol. 2010;30:2368-2371.
20. Osada M, Inoue O, Ding G, Shirai T, Ichise H, Hirayama K, Takano K, Yatomi Y, Hirashima M, Fujii H, Suzuki-Inoue K, Ozaki Y. Platelet activation receptor CLEC-2 regulates blood/lymphatic vessel separation by inhibiting proliferation, migration, and tube formation of lymphatic endo-thelial cells. J Biol Chem. 2012;287:22241-22252.
21. Hughes CE, Navarro-Núñez L, Finney BA, Mourão- Sá D, Pollitt AY, Watson SP. CLEC-2 is not required for platelet aggregation at arteriolar shear. J Thromb Haemost. 2010;8:2328-2332.
22. May F, Hagedorn I, Pleines I, Bender M, Vögtle T, Eble J, Elvers M, Nieswandt B. CLEC-2 is an essential platelet-activating receptor in hemo-stasis and thrombosis. Blood. 2009;114:3464-3472.
23. Gardiner EE, Al-Tamimi M, Mu FT, Karunakaran D, Thom JY, Moroi M, Andrews RK, Berndt MC, Baker RI. Compromised ITAM-based platelet receptor function in a patient with immune thrombocytopenic purpura. J Thromb Haemost. 2008;6:1175-1182.
24. Schulte V, Reusch HP, Pozgajová M, Varga-Szabó D, Gachet C, Nieswandt B. Two-phase antithrombotic protection after anti-glycoprotein VI treatment in mice. Arterioscler Thromb Vasc Biol. 2006;26:1640-1647.
25. David T, Ohlmann P, Eckly A, Moog S, Cazenave JP, Gachet C, Lanza F. Inhibition of adhesive and signaling functions of the platelet GPIb-V-IX complex by a cell penetrating GPIbalpha peptide. J Thromb Haemost. 2006;4:2645-2655.
26. Elvers M, Stegner D, Hagedorn I, Kleinschnitz C, Braun A, Kuijpers ME, Boesl M, Chen Q, Heemskerk JW, Stoll G, Frohman MA, Nieswandt B. Impaired alpha(IIb)beta(3) integrin activation and shear-dependent thrombus formation in mice lacking phospholipase D1. Sci Signal. 2010;3:ra1.
27. Gardiner EE, Karunakaran D, Arthur JF, Mu FT, Powell MS, Baker RI, Hogarth PM, Kahn ML, Andrews RK, Berndt MC. Dual ITAM-mediated proteolytic pathways for irreversible inactivation of platelet receptors: de-ITAM-izing FcgammaRIIa. Blood. 2008;111:165-174.
28. Zhi H, Rauova L, Hayes V, Gao C, Boylan B, Newman D, McKenzie S, Cooley B, Poncz M, Newman P. Cooperative integrin/itam signaling in platelets enhances thrombus formation in vitro and in vivo. Blood. 2012; [Epub ahead of print]
29. Rabie T, Varga-Szabo D, Bender M, Pozgaj R, Lanza F, Saito T, Watson SP, Nieswandt B. Diverging signaling events control the pathway of GPVI down-regulation in vivo. Blood. 2007;110:529-535.
30. Gupta S, Braun A, Morowski M, Premsler T, Bender M, Nagy Z, Sickmann A, Hermanns HM, Bösl M, Nieswandt B. CLP36 is a negative regulator of glycoprotein VI signaling in platelets. Circ Res. 2012; 111:1410-1420.
31. Law DA, Nannizzi-Alaimo L, Ministri K, Hughes PE, Forsyth J, Turner M, Shattil SJ, Ginsberg MH, Tybulewicz VL, Phillips DR. Genetic and pharmacological analyses of Syk function in alphaIIbbeta3 signaling in platelets. Blood. 1999;93:2645-2652.
32. Andre P, Morooka T, Sim D, et al. Critical role for Syk in responses to vascular injury. Blood. 2011;118:5000-5010.
33. Boulaftali Y, Hess P, Getz T, Cholka A, Stolla M, Mackman N, Owens A, Ware J, Kahn M, Bergmeier W. Platelet itam signaling is critical for vascular integrity in infammation. J Clin Invest. January 25, 2013; doi:pii: 65154. 10.1172/JCI65154. http://www.jci.org/articles/view/65154. Accessed March 6, 2013.